Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2005 054 367.8 |
96 | EP file number | EAKZ | 14 18 0734.7 |
97 | EP publication number | EPN | 2803366 |
54 | Designation/title | TI | Zusammensetzungen zur Behandlung oder Prävention einer Oxalat-bedingten Erkrankung |
51 | IPC main class | ICM (ICMV) | A61K 38/44 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 38/45 (2006.01), A61K 38/51 (2006.01) |
22 | DE application date | DAT | Jun 15, 2005 |
96 | EP application date | EAT | Jun 15, 2005 |
43 | Date of first publication | OT | Nov 19, 2014 |
| Date of publication of grant | PET | Aug 1, 2018 |
71/73 | Applicant/owner | INH | OxThera Intellectual Property AB, Stockholm, SE |
72 | Inventor | IN | Sidhu, Harmeet, Atlanta, GA 30306, US |
| Address for service | | Brann AB, 103 59 Stockholm, SE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 868242 Jun 15, 2004
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002803366 Searchable text:
EP000002803366 Original document:
EP000002803366B1 Searchable text:
EP000002803366B1 |
43 | Date of first publication | EVT | Nov 19, 2014 |
| Date of the first transfer into DPMAregister | EREGT | Jan 1, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | Sep 19, 2024 (Show all update days)(Hide all update days)- Sep 19, 2024
- St.36: changed (technical change)
- May 2, 2024; Apr 30, 2022; Feb 10, 2022; Jun 23, 2020; Aug 17, 2019; Jun 13, 2019; May 23, 2019; Feb 21, 2019; Sep 29, 2018; Aug 30, 2018; Jul 21, 2018; Jul 19, 2018; Feb 8, 2018
- Historical data not available for this/these date(s)
- Jan 1, 2015
- Date of the first transfer into DPMAregister
|